Lifestyle October 26, 2026 at 1:57 PM

STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO

STAT News

A targeted drug from Incyte, when used in combination with chemotherapy, induced lasting tumor responses in certain patients with pancreatic cancer

Excerpt from STAT News.

”I don’t want less pleasure. I want less eating that isn’t actually giving me pleasure.”

Moderna and Merck are racing to submit their personalized cancer vaccine for FDA approval, expected in 2027, according t…

Bristol Myers Squibb reported that one patient died after receiving its investigational CAR-T therapy in an early autoim…

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play